Physician profile
Douglas Griffith
NPI 1871551671
$3,054.99
in general payments reported to CMS, 2019-2025
18 companies · $1,276 in 2025
The $1,276 reported for 2025 was more than what 87% of Physician Assistant providers received nationally (typical 2025 total: $183).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $309 · 2022: $927 · 2023: $102 · 2024: $441 · 2025: $1,276.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,819.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,818.89 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbott Laboratories | $536.10 | 2022-2025 | Infinity, Freestyle Libre 3 |
| Axsome Therapeutics, INC. | $374.34 | 2025 | Auvelity |
| Teva Pharmaceuticals USA, INC. | $259.98 | 2024-2025 | Austedo Xr |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $224.91 | 2024-2025 | Xifaxan |
| Biohaven Pharmaceutical Holding Company LTD. | $224.18 | 2022 | |
| Si-Bone, INC. | $209.23 | 2021 | |
| Alexion Pharmaceuticals, INC. | $132.39 | 2022 | |
| Stemline Therapeutics INC. | $121.82 | 2022 | |
| Stryker Corporation | $121.78 | 2025 | Clottriever Bold Catheter |
| Genzyme Corporation | $121.36 | 2025 | |
| Gilead Sciences, INC. | $118.33 | 2024 | Epclusa |
| Ethicon US, LLC | $117.41 | 2022 | |
| Sanofi US Services INC. | $103.69 | 2025 | |
| Abbvie INC. | $101.59 | 2023 | |
| Biohaven Pharmaceuticals, INC. | $99.53 | 2021 |
Show all 18 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Novo Nordisk INC | $83.03 | 2022 | |
| Janssen Pharmaceuticals, INC | $57.70 | 2024 | Spravato |
| Ultragenyx Pharmaceutical INC. | $47.62 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Douglas Griffith listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.